2,330 mcg / 0.10 mL
Daily Dose
Overview
What is Glow Stack?
GLOW is a pre-blended 70 mg vial combining three well-studied repair peptides: GHK-Cu, TB-500 (Thymosin Beta-4 fragment), and BPC-157. Each component targets complementary pathways in tissue regeneration — collagen synthesis, cell migration, and localised repair — making the combination a multi-mechanism approach to wound healing and recovery research.
The rationale for the blend: effective tissue repair requires concurrent action on structural rebuilding (GHK-Cu), cellular mobilisation (TB-500), and localised healing and anti-inflammatory signalling (BPC-157). Delivered as a single pre-blended vial, GLOW simplifies multi-peptide protocols into a single daily injection.
✨GHK-Cu: Collagen Synthesis
Stimulates collagen I, III, fibronectin, and decorin production. Modulates thousands of genes related to skin repair, angiogenesis, and tissue remodelling.
🔄TB-500: Cell Migration
Binds actin to promote cell migration and cytoskeletal remodelling. Mobilises stem and progenitor cells to injury sites, accelerating angiogenesis and reducing fibrosis.
🩹BPC-157: Localised Repair
Enhances VEGF/PDGF receptor signalling and nitric oxide pathways. Promotes fibroblast migration via the FAK-paxillin pathway for connective tissue repair.
🧬Synergistic Action
Three complementary mechanisms — structural rebuilding, cellular mobilisation, and localised anti-inflammatory repair — operating simultaneously in a single injection.
Dosing Protocol
Dosing Schedule
Parameters documented in published preclinical and clinical research.
⚠️ Research use only. The following documents parameters from published preclinical and clinical research. Not medical advice. Not for human consumption. Consult a licensed healthcare professional before any use.
| Phase | Dose | Volume (U-100) | Duration | Notes |
|---|
| Standard | 2,330 mcg (2.33 mg) | 10 units / 0.10 mL | Weeks 1–4 | Once daily SubQ. Delivers ~1.7 mg GHK-Cu + ~0.33 mg TB-500 + ~0.33 mg BPC-157 per injection. Reconstitute with 3.0 mL BAC water → 23.3 mg/mL. |
| Off cycle | — | — | 2–4 weeks | Rest period before repeating. Assess tissue response before restarting. |
Safety Profile
Safety & Side Effects
✓ Generally Well Tolerated
All three components have favourable preclinical safety profiles
No androgenic effects from any component
Complementary, non-overlapping mechanisms reduce interaction risk
BPC-157 and TB-500 have extensive preclinical tolerability data
⚠ Potential Concerns
No human clinical trial data for the combined blend formulation
TB-500 is WADA-prohibited (Category S2)
Sourcing quality and blend accuracy critical — use COA-verified vendors only
Injection site reactions possible with daily SubQ administration
⚠️
Research use onlyThis page is an educational reference. None of this constitutes medical advice. Consult a qualified professional before any use. All compounds are for research purposes only.
Recommended Source
Source your compounds at White Market Peptides
Use code PEPPERCALC10 for 10% off + free 2-day shipping over $200
Shop Now →